4//SEC Filing
Jallal Bahija 4
Accession 0001415889-25-004602
CIK 0001671927other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:17 PM ET
Size
8.2 KB
Accession
0001415889-25-004602
Insider Transaction Report
Form 4
Jallal Bahija
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Employee Share Option (Right to Buy)
2025-02-17+405,824→ 405,824 totalExercise: $29.60Exp: 2035-02-16→ Ordinary Shares (405,824 underlying) - Award
Restricted Share Units
2025-02-17+95,270→ 95,270 total→ Ordinary Shares (95,270 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the option award shall vest on February 17, 2026, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]Each restricted share unit ("RSU") represents a contingent right to receive one ordinary share.
- [F3]The RSUs vest in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Immunocore Holdings plc
CIK 0001671927
Entity typeother
Related Parties
1- filerCIK 0001730038
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:17 PM ET
- Size
- 8.2 KB